Alerts
4371 total results. Page 106 of 175.
Jasmine K. Dela Luna, Jeffrey D. Skinner
Cannabidiol (CBD) is a naturally occurring compound derived from the hemp plant, a member of the cannabis family. Because CBD is also found in the marijuana plant (a cousin of hemp), its use fell into a legal gray area until recently.
Les Jacobowitz, Michael Lengel
Last week, most observers focused on the more than 11% drop in the stock market due to public health and related supply concerns. In response, the Federal Reserve made an aggressive 50 basis point interest rate cut on March 4, 2020.
Caroline Turner English, Dan H. Renberg, Oliver Spurgeon III*, Hillary M. Stemple
Lawmakers remain in negotiations among the three key committees in the House of Representatives: Energy & Commerce, Ways & Means, and Education & Labor, along with the Senate Committee on Health, Education, Labor and Pensions (HELP), about the best way to address surprise medical bills.
Lynn R. Fiorentino, Robert G. Edwards, Ph.D., Emily Cowley Leongini
California’s Office of Environmental Health Hazard Assessment recently added Δ9-tetrahydrocannabinol (THC) and “cannabis (marijuana) smoke” to the list of chemicals known to the state of California to cause reproductive toxicity, with an effective date of January 3, 2020.
Elliott M. Kroll, Julius A. Rousseau, III, James M. Westerlind, Richard G. Liskov
Companies across the country are canceling meetings and events over travel concerns because of the coronavirus.
Ralph V. De Martino
The U.S. Securities and Exchange Commission (SEC) issued an order that grants conditional regulatory relief for certain publicly traded company filing obligations in light of the rapidly spreading coronavirus pandemic.
Stephanie Trunk
CMS published the Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly Proposed Rule (the Proposed Rule).
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
Linda M. Jackson
In a recent opinion, the Fairfax Circuit Court deemed unenforceable the non-compete and employee non-solicitation provisions of two doctors who had performed work for the United States Army on behalf of a government contractor.
Chris L. Bollinger
California Attorney General Xavier Becerra recently released proposed modifications to his initial California Consumer Privacy Act (CCPA) regulation adjustments.
Anthony V. Lupo, Matthew R. Mills, Kelli Scheid Smith, Megan A. Rzonca
As the coronavirus continues to wreak havoc globally, long-term business implications are imminent for US companies.
Dan Jasnow
As comparison sites become more popular, the fine print becomes increasingly important for both consumers and companies.
Kay C. Georgi
International Trade Partners Kay Georgi and Marwa Hassoun have an update on OFAC’s changes to the Reporting, Procedures and Penalties Regulations, 31 CFR §§ 501, et seq. related to reporting blocked, unblocked, or rejected transactions.
Birgit Matthiesen, Matthew Nolan, Nancy A. Noonan
For those reading the tea leaves of US trade policy, an announcement earlier this week from the US International Trade Commission was an important development.
J. Michael Showalter, Jane E. Montgomery
Federal officials often conduct unannounced, sometimes intrusive inspections of regulated entities, which can be a major disruption to companies’ operations and has historically left them with little to do about it but wait for the interruption to pass – until now.
Jonathan Judge, Thomas M. Crispi
Frequently the U.S. Consumer Product Safety Commission (CPSC) shares big news at the annual meeting of the International Consumer Product Health & Safety Organization (ICPHSO), the body that brings together all stakeholders in the product safety space.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
On February 26, 2020, the National Labor Relations Board (the NLRB) issued its final rule governing joint employer status under the National Labor Relations Act (the NLRA).
Yesterday, the National Labor Relations Board (NLRB or Board) issued its much anticipated final rule on the joint-employer standard under the National Labor Relations Act (NLRA).
Jasmine K. Dela Luna
The U.S. Environmental Protection Agency (EPA) announced last week its latest step in the implementation of its Action Plan—a preliminary regulatory determination regarding two per- and polyfluoroalkyl substances (PFAS)—perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS).
Joel M. Wallace
The U.S. Food and Drug Administration (FDA) issued a final rule last week that broadened the scope of the Biologics Price Competition and Innovation Act (BPCIA) to include large proteins, even those that could have been previously governed by the Hatch-Waxman Act.
The Consumer Financial Protection Bureau (Bureau) seeks industry feedback and public comment on various aspects of the remittance rule (Rule), which implements Section 1073 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act).
Tracy L. McLaughlin
The Setting Every Community Up for Retirement Enhancement (SECURE) Act, which was signed into law in December 2019, introduces a number of new rules and provisions that impact retirement savings in both employer-sponsored and individual retirement plans.
Sarah L. Lode, Jeffrey D. Skinner
Manufacturers are used to defending strict product liability actions when plaintiffs claim that their products are defective. But in the opioid litigation, plaintiffs have filed something else: more than 2,500 public nuisance cases so far.
Joel M. Wallace
The First Circuit handed the generic pharmaceutical industry an early Valentine’s Day treat earlier this month by resuscitating an antitrust suit against Sanofi by direct purchasers of insulin glargine.